Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
0.002 AUD 0.00(0%)
Last update at 2026-11-04T23:00:00Z
Market Cap
9.39M

Momentum Score

…

Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading. It sells its products through a network of B2B wholesale, retail distribution, and e-commerce platforms. The company was formerly known as AuMake Limited and changed its name to Xenitra Limited in March 2026. Xenitra Limited was incorporated in 2011 and is based in Brisbane, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Xenitra Limited is an Australian-listed company; publicly available disclosures about its business, assets and operations are limited. Because details are sparse, major long-term growth drivers are unclear and will depend on future disclosure about strategy, asset development or revenue generation, so investors may find the company of interest only if management provides clearer evidence of scalable operations or valuable assets.

Key investment risks include information and liquidity risk, potential lack of operating revenues, dependence on external financing, small-cap market volatility and execution risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
20.34M
Revenue Per Share
0.01
Gross Profit TTM
-0.40M
Debt / Equity
4.81
ROE
-378.26%
Net Debt
-1.94M
ROCE
-1973.31%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -5.38M -3.40M -6.24M -2.95M -6.21M
Minority interest - -0.08M -0.04M -0.08M 0.03M
Net income -5.18M -3.48M -6.28M -3.03M -6.18M
Selling general administrative - 4.09M 2.79M 2.14M 4.09M
Gross profit -2.25M 0.97M 0.84M 0.06M 0.55M
Reconciled depreciation - 0.09M 0.39M 0.46M 1.34M
Ebit -5.54M - - - -
Ebitda -5.47M - - - -
Depreciation and amortization 0.07M - - - -
Operating income -5.54M -3.48M -2.43M -2.56M -4.90M
Other operating expenses 25.65M - - - -
Tax provision - 0.00M 0.00M 0.00M 0.00M
Interest income - 0.01M 0.01M 0.01M 0.02M
Net interest income - 0.01M 0.01M 0.01M 0.02M
Total revenue 20.11M 39.77M 25.87M 2.67M 6.01M
Total operating expenses 3.30M - - - -
Cost of revenue 22.36M 38.80M 25.02M 2.61M 5.46M
Total other income expense net 0.17M 0.07M -3.83M -0.39M -1.32M
Net income from continuing ops - -3.40M -6.24M -2.95M -6.21M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 4.44M 8.30M 4.42M 6.37M 10.08M
Intangible assets 0.11M - - 4.20M -
Other current assets 0.72M - - - -
Total liab 4.26M 5.64M 3.80M 1.26M 5.98M
Total stockholder equity 0.25M 2.55M 0.52M 5.11M 4.13M
Other current liab 0.99M - - - -
Common stock 67.36M - - - -
Capital stock - 64.57M 59.08M 57.42M 53.81M
Retained earnings -67.00M -63.55M -60.72M -54.69M -51.77M
Good will - - - - 4.50M
Cash 3.16M 1.68M 1.99M 1.39M 3.04M
Total current liabilities 4.16M 5.50M 1.54M 1.26M 5.92M
Current deferred revenue 1.05M - - - -
Net debt -1.94M - 0.21M - -
Short term debt 1.11M - - - -
Short long term debt - 1.03M 0.03M - -
Short long term debt total 1.21M - - - -
Total current assets 4.09M 7.89M 3.85M 1.92M 4.61M
Long term investments - 0.19M 0.20M 0.08M 0.08M
Short term investments - 0.05M 0.05M 0.16M -
Net receivables 0.21M 3.00M 0.53M 0.01M 0.08M
Long term debt - 0.13M 2.16M - -
Inventory 0.00M 2.93M 1.22M 0.32M 1.42M
Accounts payable 1.01M 2.23M 0.59M 0.16M 2.23M
Accumulated other comprehensive income -0.10M - - - -
Non currrent assets other 0.13M 0.02M 0.08M - -
Non current assets total 0.35M 0.41M 0.56M 4.45M 5.46M
Capital lease obligations - - - - 0.52M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Net borrowings - - 2.19M - -
Total cash from financing activities 2.58M 3.93M 3.58M 2.00M 4.72M
Net income -5.18M -3.48M -6.28M -3.03M -6.18M
Change in cash 1.48M -0.36M 0.61M -1.65M -0.98M
Begin period cash flow 1.68M 1.99M 1.39M 3.04M 4.26M
End period cash flow 3.16M 1.68M 1.99M 1.39M 3.04M
Total cash from operating activities -1.13M - - - -
Issuance of capital stock - 4.08M 1.49M 2.13M 4.85M
Depreciation 0.07M - - - -
Change to inventory 2.92M - - - -
Change to account receivables 2.76M - - - -
Sale purchase of stock - -0.12M -0.09M -0.02M -0.13M
Capital expenditures 0.01M 0.01M 0.19M 0.00M 0.71M
Change in working capital 3.91M - - - -
Other non cash items 0.07M - - - -
Free cash flow -1.14M -4.26M -2.84M -3.46M -6.26M

Peer Comparison*

Sector: Consumer Cyclical Industry: Department Stores

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
XEN
Xenitra Limited
-
-%
0.00 - 1.19 0.46 37.26 0.37 -0.77
BGP
Briscoe Group Australasia Ltd
-
-%
3.00 13.64 11.89 0.83 2.76 1.42 8.51
MYR
Myer Holdings Ltd
-0.01
3.85%
0.25 - 5.56 0.11 0.63 0.52 44.15

Profile*

Xenitra Limited

Xenitra Limited operates as a brand acceleration, market-access, and distribution company in Australia, Hong Kong, and Mainland China. It offers functional and medical food, such as infant formula, and vitamin mineral and supplement category products; over the counter products, such as non-prescription small molecule medicines and structure function benefit complementary medicines; fast-moving consumer goods (FMCG); nutraceuticals; health and wellness; and personal care products, as well as involved in real world asset tokenisation and nutritional product trading. It sells its products through a network of B2B wholesale, retail distribution, and e-commerce platforms. The company was formerly known as AuMake Limited and changed its name to Xenitra Limited in March 2026. Xenitra Limited was incorporated in 2011 and is based in Brisbane, Australia.

270 Adelaide Street, Brisbane, QLD, Australia, 4000

61 1800 800 285

Name Title Year Born
Mr. Anthony Guarna Chief Financial Officer NA
Mr. Zhiguo Zhang Group Chief Operating Officer NA
Mr. Sebastian Andre Company Secretary NA
Mr. Chen Zhenghai Group General Manager NA
Ms. Zhao Zhang Head of China NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…